Pharmaceutical News

RSS

Increased drug coverage restrictions in Medicare Part D raises concerns

Medicare Part D plans significantly increased restrictions on prescription drugs, excluding more compounds from coverage or subjecting more of them to review before patients could access the treatments, according to a new study from USC researchers.

4 Mar 2024

Research validates concurrent use of HIV medications and gender-affirming hormone therapy

New research definitively shows that HIV antiretrovirals can be taken together with gender-affirming hormone therapy without changing how well either drug works.

4 Mar 2024

SolasCure publishes phase IIa clinical trial report in leading wound care journal

Study demonstrates proof-of-concept and strong safety profile of Aurase Wound Gel in patients suffering from chronic wounds.

From SolasCure 4 Mar 2024

How a friend’s death turned Colorado teens into anti-overdose activists

Gavinn McKinney loved Nike shoes, fireworks, and sushi. He was studying Potawatomi, one of the languages of his Native American heritage.

1 Mar 2024

Exercise, GLP-1 receptor agonist, or combined approach explored in year-long study

Researchers compare the extent of weight loss after one-year termination of active intervention with GLP-1 receptor agonist, exercise, or combination.

29 Feb 2024

BioCina and NovaCina forge strategic alliance to offer biologics developers integrated drug substance and drug product solutions

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina Pty Ltd., a global fill-and-finish CDMO, announced a strategic partnership to provide integrated drug substance and drug product solutions for biologics developers.

From BioCina Pty Ltd. 29 Feb 2024

Study: Many approved cancer drugs lack proof of added benefit

Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved through expedited ("fast track") pathways, finds a study published by The BMJ today.

28 Feb 2024

Anti-cancer drug shows promise in treating brain injuries after stroke

A study by the Institut de Neurociències of the UAB (INc-UAB) demonstrates in animal models the benefits of vorinostat after having suffered a stroke.

28 Feb 2024

An Arm and a Leg: Wait, is Insulin cheaper now?

Pharmaceutical companies that manufacture insulin made headlines last year when they voluntarily agreed to provide discount cards that lower the monthly cost of insulin for many people to $35.

28 Feb 2024

Aston University and PDA collaboration to examine pharmacists' expanded duties in healthcare

A partnership between Aston University and the Pharmacists' Defence Association (PDA) is to examine the feasibility of extending pharmacists' duties to include more healthcare interventions, such as blood pressure checks and cholesterol screening.

27 Feb 2024

Omalizumab boosts tolerance to multiple food allergies, study finds

A study in The New England Journal of Medicine shows omalizumab increases allergen tolerance in individuals with multiple food allergies, offering a promising standalone treatment option.

26 Feb 2024

Study finds October-born kids less likely to catch flu post-vaccination

Study shows October as the optimal month for influenza vaccination in young children, aligning with CDC guidelines to maximize protection against seasonal flu.

26 Feb 2024

Study finds sharp increase in antidepressant dispensing among adolescents and young adults during COVID-19 pandemic

Antidepressant dispensing to adolescents and young adults increased sharply after the COVID-19 pandemic began – particularly among females – a new study finds.

26 Feb 2024

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

A study published in Immunity shows that antibody responses to SARS-CoV-2 infection and vaccination are long-lasting, with an initial decline followed by stabilization after seven to nine months, highlighting the effectiveness of mRNA vaccines and the importance of hybrid immunity.

25 Feb 2024

Omalizumab shows promise in preventing food allergy reactions in children, study finds

A drug can make life safer for children with food allergies by preventing dangerous allergic responses to small quantities of allergy-triggering foods, according to a new study led by scientists at the Stanford School of Medicine.

25 Feb 2024

Reevaluating the role of direct oral anticoagulants in cardiovascular treatment

Direct oral anticoagulants (DOACs) are a common treatment for patients with a wide variety of cardiovascular conditions.

23 Feb 2024

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The University of Texas at Austin.

23 Feb 2024

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

The University of Texas MD Anderson Cancer Center today announced it has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDe switch platform and the GoCAR platform.

22 Feb 2024

Selkirk Pharma announces new APS qualified facility with advanced fill/finish capacity in Spokane, WA

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the Aseptic Process Simulation (APS) qualification of its sterile manufacturing facility and newly available fill/finish capacity.

From Selkirk Pharma 22 Feb 2024

Machine learning enhances understanding of drug absorption

Before orally administered drugs can make their way throughout the body, they must first bind to membrane proteins called drug transporters, which carry compounds across the intestinal tract and help them reach their intended targets.

21 Feb 2024

Pharmaceutical News

Increased drug coverage restrictions in Medicare Part D raises concerns

Research validates concurrent use of HIV medications and gender-affirming hormone therapy

SolasCure publishes phase IIa clinical trial report in leading wound care journal

How a friend’s death turned Colorado teens into anti-overdose activists

Exercise, GLP-1 receptor agonist, or combined approach explored in year-long study

BioCina and NovaCina forge strategic alliance to offer biologics developers integrated drug substance and drug product solutions

Study: Many approved cancer drugs lack proof of added benefit

Anti-cancer drug shows promise in treating brain injuries after stroke

An Arm and a Leg: Wait, is Insulin cheaper now?

Aston University and PDA collaboration to examine pharmacists' expanded duties in healthcare

Omalizumab boosts tolerance to multiple food allergies, study finds

Study finds October-born kids less likely to catch flu post-vaccination

Study finds sharp increase in antidepressant dispensing among adolescents and young adults during COVID-19 pandemic

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

Omalizumab shows promise in preventing food allergy reactions in children, study finds

Reevaluating the role of direct oral anticoagulants in cardiovascular treatment

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

Selkirk Pharma announces new APS qualified facility with advanced fill/finish capacity in Spokane, WA

Machine learning enhances understanding of drug absorption

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News